Considering that the plasma level of BAFF is elevated in patients with SLE, CVID, and CLL, the increased sTACI level may be related to feedback mechanisms by which the organism regulates the degree of BAFF activity. The gene discussed is TNFSF13B; the disease is B-cell chronic lymphocytic leukemia.